Article
Acquired C1 esterase inhibitor deficiency in lymphomas: prevalence, symptoms, and response to treatment.
Leukemia & lymphoma - 1 Sept 2016
Bekos Christine, Perkmann Thomas, Krauth Maria, Raderer Markus, Lechner Klaus, Jaeger Ulrich
Abstract excerpt
We retrospectively studied the prevalence of C1 esterase inhibitor (C1 INH) deficiency in 131 patients with various lymphomas. We determined C1 INH activity, C1 INH antigen, and C4 concentration at diagnosis and after chemotherapy. In follicular lymphoma (FL), diffuse large B-cell lymphoma (DLBCL) and chronic lymphocytic leukemia (CLL) consecutive patients were studied. In these entities, the prevalence of C1 INH...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
